N/A N=118 Randomized Treatment

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Diabetes · Hypertension · Dyslipidemia · Coronary Arteriosclerosis

Bottom Line

View on ClinicalTrials.gov: NCT00357955 ↗

Enrolled (actual)

118

Serious AEs

0.9%

Results posted

May 2014

Primary outcome: Primary: Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg — 40.4; 21.6; 65.5; 39.9 percentage

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Behavioral counseling and peer support (Behavioral); Interactive Education (Behavioral); Role modeling (Behavioral); Pharmacologic case management (Procedure)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Providence VA Medical Center
Primary completion: May 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg	40.4; 21.6; 65.5; 39.9; 87.9; 68.6	—

Summary

The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.

Eligibility Criteria

Inclusion Criteria

All diabetic veterans with a Hb-A1c between 7.0- 9.0 % within the last 6 months will be eligible for the study

Exclusion Criteria

Patients without an Hb-A1c checked within the last 6 months.
Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00357955). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.